These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31627175)

  • 21. Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.
    Li M; Xie Y; Zhang J; Zhou X; Gao L; He M; Liu X; Miao X; Liu Y; Cao R; Jia Y; Zeng Z; Liu L
    Cancer Lett; 2024 Aug; 598():217111. PubMed ID: 38972347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
    Lin L; Benson DM; DeAngelis S; Bakan CE; Li PK; Li C; Lin J
    Int J Cancer; 2012 Mar; 130(6):1459-69. PubMed ID: 21520044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.
    Schust J; Sperl B; Hollis A; Mayer TU; Berg T
    Chem Biol; 2006 Nov; 13(11):1235-42. PubMed ID: 17114005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells.
    Ball S; Li C; Li PK; Lin J
    PLoS One; 2011 Apr; 6(4):e18820. PubMed ID: 21526200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
    Lin L; Liu A; Peng Z; Lin HJ; Li PK; Li C; Lin J
    Cancer Res; 2011 Dec; 71(23):7226-37. PubMed ID: 21900397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
    Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
    Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas.
    Thornber K; Colomba A; Ceccato L; Delsol G; Payrastre B; Gaits-Iacovoni F
    Oncogene; 2009 Jul; 28(29):2690-6. PubMed ID: 19503098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.
    Li CH; Xu LL; Jian LL; Yu RH; Zhao JX; Sun L; Du GH; Liu XY
    Int Immunopharmacol; 2018 May; 58():136-144. PubMed ID: 29587202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [STAT3 inhibitor Stattic induced IL-8 production and cell apotosis in THP-1 cells by activating ERK pathway].
    Xiao Z; Chen M; Yang M; Chen X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jun; 35(6):498-504. PubMed ID: 31292053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
    Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetyl cysteine regulates the phosphorylation of JAK proteins following CD40-activation of human memory B cells.
    Bonnaure G; Néron S
    Mol Immunol; 2014 Nov; 62(1):209-18. PubMed ID: 25016575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3.
    Kasprzycka M; Marzec M; Liu X; Zhang Q; Wasik MA
    Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9964-9. PubMed ID: 16766651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer.
    Wang Y; Hu Z; Ma W; Niu Y; Su J; Zhang L; Zhao P
    Invest New Drugs; 2021 Jun; 39(3):764-774. PubMed ID: 33245464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).
    Marzec M; Zhang Q; Goradia A; Raghunath PN; Liu X; Paessler M; Wang HY; Wysocka M; Cheng M; Ruggeri BA; Wasik MA
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20852-7. PubMed ID: 19088198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.
    Bid HK; Oswald D; Li C; London CA; Lin J; Houghton PJ
    PLoS One; 2012; 7(4):e35513. PubMed ID: 22530037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M; Li C; Lin J; Javle M
    Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells.
    Tierney BJ; McCann GA; Cohn DE; Eisenhauer E; Sudhakar M; Kuppusamy P; Hideg K; Selvendiran K
    Cancer Biol Ther; 2012 Jul; 13(9):766-75. PubMed ID: 22801507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of quinalizarin induces apoptosis and G0/G1 cell cycle of human esophageal cancer HCE-4 cells depends on MAPK, STAT3, and NF-κB signaling pathways.
    Zang YQ; Zhai YQ; Feng YY; Ju XY; Zuo F
    Environ Toxicol; 2021 Feb; 36(2):276-286. PubMed ID: 33030807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and
    Oleksak P; Psotka M; Vancurova M; Sapega O; Bieblova J; Reinis M; Rysanek D; Mikyskova R; Chalupova K; Malinak D; Svobodova J; Andrys R; Rehulkova H; Skopek V; Ngoc Lam P; Bartek J; Hodny Z; Musilek K
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):410-424. PubMed ID: 33440995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.
    Zhang R; Chen X; Fu S; Xu L; Lin J
    Oncol Rep; 2020 Sep; 44(3):1224-1232. PubMed ID: 32705214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.